Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial.
Journal: The Lancet. Oncology
Published: September 23, 2021
Modulation of the Human Pancreatic Ductal Adenocarcinoma Immune Microenvironment by Stereotactic Body Radiotherapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 07, 2021
Long-Term Outcomes of NRG Oncology/RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Anal Canal Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: April 19, 2021
Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical Trial.
Journal: American journal of clinical oncology
Published: January 28, 2020
Hypofractionated Stereotactic Radiation Therapy for Metastatic Adenocarcinoma ex Goblet Cell Carcinoid of the Appendix: Case Report and Literature Review.
Journal: Case reports in oncology
Published: October 01, 2019
Stereotactic body radiation therapy versus metastasectomy for oligometastases.
Journal: Journal of thoracic disease
Published: June 11, 2019
Short course radiation therapy for rectal cancer in the elderly: can radical surgery be avoided?
Journal: Journal of gastrointestinal oncology
Published: April 30, 2019
Hypofractionated Stereotactic Radiotherapy for Non-breast or Prostate Cancer Oligometastases: A Tail of Survival Beyond 10 Years.
Journal: Frontiers in oncology
Published: December 05, 2018
NRG Oncology/RTOG 0438: A Phase 1 Trial of Highly Conformal Radiation Therapy for Liver Metastases.
Journal: Practical radiation oncology
Published: October 31, 2018
Oligometastatic breast cancer treated with hypofractionated stereotactic radiotherapy: Some patients survive longer than a decade.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: October 24, 2018
Impact of Right-sided Primary Tumor Location Among Patients With Oligometastatic Colorectal Cancer Treated With Stereotactic Body Radiotherapy.
Journal: American journal of clinical oncology
Published: April 18, 2018
SBRT for Hepatocellular Carcinoma: 8-Year Experience from a Regional Transplant Center.
Journal: Journal of gastrointestinal cancer
Published: July 16, 2017
Last Updated: 09/26/2026